Although the World Health Organization (WHO) categorizes spinal ependymomas into three histological grades, difference in surgical outcomes between WHO grades I and II tumors are unclear. For these benign tumors, prognosis may be best determined by factors other than tumor grade alone, such as extent of resection. To analyze the effects of the extent of resection on different grades of spinal ependymomas, we performed a comprehensive literature review to identify adult spinal ependymoma patients who received surgical resection with a clearly identifiable WHO grade. A total of 175 patients were identified. While grade III tumors carried the worst prognosis as expected (p < 0.001), grade I and II tumors did not differ significantly in outcomes following surgery. Overall, gross total resection (GTR, 68.7%, 114/166) provided significantly improved progression-free survival (PFS, p < 0.001) and overall survival (OS, p = 0.022) compared to the subtotal resection group. Surprisingly, the highest GTR rate was achieved for grade II tumors (78.8%, 78/99; p < 0.001) followed by grade I (58.9%, 33/56) and grade III tumors (27.3%, 3/11). Interestingly, PFS was significantly improved by GTR for grade II tumors (p < 0.001), but not for grade I (p = 0.705). Similar trends, although not statistically significant, were found for OS. Our results show that while GTR provides the best overall outcomes, GTR is most effective for classic grade II ependymomas, but not for grade I ependymomas. Despite having a lower WHO grade, myxopapillary ependymomas have a lower GTR rate, and benefit less from GTR.
Introduction
Ependymomas make up 3-6% of all central nervous system tumors [1] [2] [3] and are thought to arise from radial glial cells that line the ventricles and spinal cord. 4, 5 Approximately 75% of these tumors occur in the spine, 6 making them the most common glial tumors of the adult spine. 2, 3, [7] [8] [9] [10] [11] While spinal ependymomas generally have a better prognosis compared to other intramedullary glial tumors, 9 ,12 a significant portion of tumors can recur, leading to debilitating morbidities and mortality. While most ependymomas are considered histologically benign, recurrence rates can be as high as 50-70% without adjuvant therapy 3, 8, 13 with a potential for widespread metastases. [14] [15] [16] [17] [18] Thus, studies identifying preoperative features that can help predict outcomes are critical, not only for guiding treatment but in counseling patients before surgery. One such factor shown to affect prognosis is the tumor grade. [19] [20] [21] The World Health Organization (WHO) currently classifies ependymomas into three grades: grade I tumors include myxopapillary ependymomas and subependymomas; grade II includes classic ependymomas (consisting of cellular, papillary, clear cell, giant cell, and tanycytic subtypes); and grade III includes anaplastic ependymomas. 22 While these grades help guide treatment, such as use of adjuvant radiotherapy, [23] [24] [25] [26] [27] the prognostic value of this grading system is controversial. 2 The prognostic value of distinguishing grade II and III tumors, for example, has been debated in regards to pediatric ependymomas. 28 Moreover, the genetic heterogeneity of ependymomas of different subtypes, and even of the same histologic grade from spine and brain, make it difficult to establish tumor characteristics and prognosis based on WHO grade alone. 29 [23] [24] [25] [26] [27] 38 and how these factors are related is needed to better determine the prognosis of spinal ependymoma patients. The extent of resection with gross total resection (GTR) has been considered the most consistent variable in predicting good outcomes. [1] [2] [3] Thus, the gold-standard therapy for spinal ependymomas remains en bloc GTR over piecemeal subtotal resection (STR). [30] [31] [32] [33] [34] [35] [36] There are significant morbidities associated with surgery including limb weakness, sensory loss, dysesthesia, bowel and bladder dysfunction, wound infections, and cerebrospinal fluid leaks. 39 These risks likely increase whenever aggressive resection is attempted. Given the critical role of the extent of resection in determining outcomes, we sought to analyze the association between the extent of resection and histological grade, specifically focusing on the two benign grades (WHO grade I and II), to determine whether aggressive surgical resection is more appropriate for certain tumors. We analyzed previously published patient data to determine how spinal ependymomas, stratified by WHO grade, are affected by extent of resection.
Methods

Article selection
A comprehensive systematic review of the English-language literature was carried out. An integrative analysis was performed, where individual patient data from studies was pooled and statistically analyzed. Articles were identified via a PubMed search using the key word ''ependymoma'', and all manuscripts were individually reviewed to identify surgical spinal ependymoma patients where the WHO grade of tumor was clearly identifiable. Tumors reported as ''benign'' without specifying grade I versus grade II were omitted. Only patients 18 years of age and older were included. We identified 43 articles with total of 175 patients who met the criteria. 15, 18, 25, 36, Aggregated data sets, where individual patient data were grouped, were not included in this analysis.
Data extraction
Data from case reports and institutional series were extracted with the following information: age, sex, WHO grade, extent of resection (GTR versus STR), adjuvant radiotherapy, recurrence or progression of disease, time to recurrence or progression of disease, mortality, time to mortality, tumor location (upper spinal: cervicomedullary, cervical, and cervicothoracic; lower spinal: thoracic, thoracolumbar, conus and cauda equina), and duration of follow-up. All mean values are presented with standard error of mean.
Statistical analysis
Progression-free survival (PFS) and overall survival (OS) were analyzed by building Kaplan-Meier curves and differences assessed by log-rank test. The Cox proportional hazards model was fitted by backward stepwise model selection while accounting for confounding variables, including age, sex, tumor grade, tumor location, and adjuvant radiotherapy. Means of continuous variables were analyzed using analysis of variance, and categorical values were analyzed using the Pearson's chi-squared test. Fisher's exact test was used if the expected cell count in a contingency table was less than five. p values less than 0.05 were considered statistically significant. Analyses were performed using the Statistical Package for the Social Sciences 20 (SPSS Inc., Chicago, IL, USA).
Results
Clinical characteristics
The literature search yielded 43 manuscripts with 175 patients who underwent surgical treatment for spinal ependymomas with clearly identifiable WHO grade. 15, 18, 25, 36, The mean age was 39.5 years with a range of 18-81. There was a significant difference in the mean age across tumor grades (p = 0.025) with the youngest age in the grade III (34.31 ± 3.85) and the oldest age in grade II (41.91 ± 1.33) groups (Table 1) . Overall, there were more men (54.7%, 88/161) but sex was not associated with tumor grade (p = 0.866). The mean follow-up duration was 48.8 months (range, 0-240 months).
The overall GTR rate was 68.7% (114/166). There was a significant difference in the extent of resection by tumor grade (Table 1 ; p < 0.001). As expected, the GTR rate was lowest for grade III lesions (27.3%, 3/11). Unexpectedly, grade I tumors were found to have a lower GTR rate compared to grade II tumors (58.9%, 33/56 versus 78.8%, 78/99, respectively; p < 0.001). Moreover, adjuvant radiotherapy was used at a higher rate for grade I tumors (48.2%, 27/56) compared to grade II tumors (11.1%, 11/99; p < 0.001), likely due to the lower GTR rate in the grade I tumors. In fact, adjuvant therapy was used at a similar rate for patients with grade I and anaplastic tumors. We also analyzed tumor location for different histologic types and found that grade I myxopapillary tumors were mainly localized to the lower spine (85.2%, 52/61), consistent with previous reports. 20, 30, 32 
GTR provides improved outcomes
We first performed a Kaplan-Meier analysis to determine the effects of extent of resection on PFS and OS. Clearly, GTR provided better outcomes with respect to both PFS ( Fig. 1a ; p < 0.001) and OS ( Fig. 1b ; p = 0.022) compared to STR. These findings were confirmed by a multivariate Cox proportional hazards analysis, while controlling for other confounding variables, such as age, sex, tumor grade, tumor location, and adjuvant radiotherapy. Extent of resection (STR versus GTR) remained a significant factor for improved PFS with a hazard ratio of 7.35 (95% confidence interval 3.31-16.32; p < 0.01).
Anaplastic ependymomas portend poor prognosis
We then constructed Kaplan-Meier curves after stratifying patients by WHO grade (Fig. 2) . As expected, grade III tumors were associated with worse outcomes. Both PFS (grade I versus III and grade II versus III, p < 0.001) and OS (grade I versus III and grade II versus III, p < 0.001) were worse for grade III tumors compared to other WHO grades. However, there was no difference between grade I and grade II tumors for both PFS (p = 0.406) and OS (p = 0.499). These results suggest that while grade III tumors portend a poor prognosis, the distinction between myxopapillary grade I ependymomas and classic grade II tumors is, in terms of prognosis, small and non-significant.
Benefits of GTR are dependent on tumor grade
Given that outcomes were similar for the WHO grade I and II tumors, we wanted to investigate how different grades of tumors are affected by the extent of resection. We felt this analysis would be critically valuable as some authors have suggested that tumor grade alone is an insufficient indicator of prognosis, 2,29 while extent of resection is considered the most consistent prognostic factor. 1-3 Thus, we wanted to evaluate how tumor grade and extent of resection affect outcomes in combination. Surprisingly, we found that GTR did not provide added benefits for the grade I tumors for either PFS (p = 0.705) or OS (p = 0.386) (Fig. 3 ). There were four recurrences out of 33 patients in the GTR group, and six recurrences out of 23 patients in the STR group. The mortality rate was very low for grade I patients with only one death out of 51 patients.
By contrast, PFS was significantly affected by the extent of resection in patients with grade II tumors ( Fig. 4a ; p = 0.001). Patients who received GTR had significantly longer PFS compared to those who received STR. There was only one recurrence out of 77 patients in the GTR group, while six out of 21 patients recurred in the STR group. Difference in OS, although present, did not reach a statistical significance ( Fig. 4b ; p = 0.213) with one death out of 78 patients in the GTR group and two deaths out of 22 patients in the STR group. The difference in PFS (p = 0.162) and OS (p = 0.391) by the extent of resection also did not reach statistical significance for the anaplastic tumors (data not shown), although this is likely contributable to small sample size (GTR = 3, STR = 8) and the lack of events in the control (GTR) group: mainly, there were no recurrences or deaths in three patients who received GTR. By contrast, six recurred and five died out of eight patients with anaplastic tumors who received STR. Thus, patients in the STR group trended toward worse outcomes compared to those in the GTR group.
Discussion
Although surgery is accepted as the mainstay therapy for spinal ependymomas, 1-3,30-36 the benefits of aggressive surgery must be weighed against the inherent risk of severe neurological deficits and other serious complications associated with surgery. 39 An improved understanding of the factors affecting outcomes can help guide the surgeon's decision on when aggressive surgical resection is appropriate, despite the possibility of serious complications. Thus, we analyzed how extent of resection affects outcomes of spinal ependymoma patients with different WHO grades using previously published data. Our results show that GTR is significantly superior to STR with respect to PFS and OS (Fig. 1) as previously reported. [30] [31] [32] [33] [34] [35] [36] This result remained significant in our multivariate Cox regression analysis (hazard ratio 7.35, p < 0.01), even while adjusting for the effects of adjuvant radiotherapy. Overall GTR rate was quite high (68.7%), implying that optimal surgical outcomes can be achieved in at least two out of three patients with this disease. This was consistent with previously reported results. GTR rate was lower in grade I tumors (58.9%) compared to grade II tumors (78.8%, p < 0.001). There are likely many tumor features that affect the surgeon's ability to achieve GTR, such as nerve root involvement, extradural versus intradural location, and involvement of the bony spine (i.e. sacrum). Since myxopapillary tumors occur more frequently in the lower spine (p < 0.001) (i.e. filum terminale, cauda equina, and sacrum), 20, 30 we hypothesize that the technical challenges associated with surgical resection in this anatomic region are likely responsible for the observed phenomenon. Furthermore, the infiltrative nature also likely affects the extent of resection, as demonstrated by the low GTR rate for anaplastic ependymomas (27.3%, p < 0.001). While anaplastic tumors consistently demonstrated the worst prognosis when stratifying by histological grade, grade I tumors did not fare significantly better compared to grade II tumors, as might be expected (Fig. 2) . Interestingly, both PFS (p = 0.406) and OS (p = 0.499) were similar for grade I and grade II tumors. This was despite having lower GTR rate for the grade I tumors. However, more grade I tumors were treated with adjuvant radiotherapy (48.2%) compared to grade II tumors (11.1%); this would be expected to offset the lower rates of GTR among grade I tumors, but the difference in PFS and OS was still not significantly different compared to grade II lesions. Moreover, additional analysis after stratifying by tumor grade showed that GTR did not play a significant role in prolonging PFS for the grade I tumors (Fig. 3a) , but GTR significantly improved PFS for the grade II tumors (Fig. 4a) . The exact reasons for this finding are unclear, although differences in the genetics and molecular biology associated with different histological subtypes 29 likely result in different tendencies for recurrence.
Furthermore, GTR may be more difficult to obtain for grade I tumors than perceived by surgeons during surgery, as microtumors may be left behind on nerve roots, cauda equina, or filum terminale as the tumors are peeled away from these structures. It is also possible that myxopapillary grade I ependymomas are inherently more aggressive than grade II tumors, requiring adjuvant radiotherapy in order to achieve similar PFS and OS. Overall, our results indicate that WHO grade I spinal ependymomas do not fare better in outcomes compared to grade II tumors, suggesting that the current WHO grading system may need a further review, if it were to more accurately predict outcomes. While we could not make firm conclusions about the role of the extent of resection for anaplastic ependymomas due to the small sample size, clear trends were seen for this histological grade. There were no recurrences or deaths in the three patients who received GTR. However, among the eight patients who underwent STR, six recurred and five died. We suspect that differences between the GTR and STR groups would reach a statistical significance with a larger population and that PFS and OS are both improved by GTR.
Because this is a retrospective analysis of pooled individual patient data from multiple studies, there are inherent limitations involved with this method. Individual patient data may not accurately reflect spinal ependymoma patients as a whole, since aggregated patient data (where individual patient data were grouped) was not used in this study. The extent of resection, which was determined by the surgeons or by postoperative imaging, may not be consistently reported across different studies due to surgeon or radiologist bias. Studies are also more likely to only report patients with good outcomes, and may be biased toward better outcomes than in reality. The differences in patient management at different institutions, such as the surgeon's level of experience, whether adjuvant radiotherapy is used or not, follow-up protocol, and protocols involving treatment of recurrent tumors are not taken into account in this study and may affect results presented in this study.
Conclusion
The best outcomes for spinal ependymomas are achieved with GTR. More specifically, the classic grade II ependymomas may benefit most from aggressive resection. While myxopapillary grade I ependymomas did not have clear benefits from GTR, we hypothesize that this may be due to greater difficulty in achieving a ''pure'' GTR than previously perceived by gross appearance during surgery. While conclusions regarding anaplastic ependymomas are difficult to make, due to the small sample size and lack of events in the control GTR group, we hypothesize that aggressive resection likely benefits this tumor grade as well, given the trends found in our study. While GTR should be attempted whenever possible, further studies looking at the role of adjuvant radiotherapy for myxopapillary ependymomas, regardless of extent of resection, are clearly warranted.
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